These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 2989413)

  • 1. Early events in Epstein-Barr virus infection provide a model for B cell activation.
    Thorley-Lawson DA; Mann KP
    J Exp Med; 1985 Jul; 162(1):45-59. PubMed ID: 2989413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BLAST-2 [EBVCS], an early cell surface marker of human B cell activation, is superinduced by Epstein Barr virus.
    Thorley-Lawson DA; Nadler LM; Bhan AK; Schooley RT
    J Immunol; 1985 May; 134(5):3007-12. PubMed ID: 2984280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.
    Wang F; Gregory CD; Rowe M; Rickinson AB; Wang D; Birkenbach M; Kikutani H; Kishimoto T; Kieff E
    Proc Natl Acad Sci U S A; 1987 May; 84(10):3452-6. PubMed ID: 3033649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation.
    Cohen JI; Wang F; Mannick J; Kieff E
    Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9558-62. PubMed ID: 2556717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infection of mouse lymphocytes by Epstein-Barr virus. II. Stimulation of cellular DNA synthesis by EBV in the absence of EBNA induction and cell transformation.
    Gross TG; Volsky DJ
    Virology; 1984 Feb; 133(1):211-5. PubMed ID: 6322431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus susceptibility of normal human B lymphocyte populations.
    Aman P; Ehlin-Henriksson B; Klein G
    J Exp Med; 1984 Jan; 159(1):208-20. PubMed ID: 6319530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus (EBV) nuclear antigen 6 induces expression of the EBV latent membrane protein and an activated phenotype in Raji cells.
    Allday MJ; Crawford DH; Thomas JA
    J Gen Virol; 1993 Mar; 74 ( Pt 3)():361-9. PubMed ID: 8383171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the transformation of human lymphocytes by Epstein-Barr virus. I. Sequential occurrence from the virus-determined nuclear antigen synthesis, to blastogenesis, to DNA synthesis.
    Takada K; Osato T
    Intervirology; 1979; 11(1):30-9. PubMed ID: 218892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of viral gene expression and genome persistence in CD23-positive and -negative subpopulations of Epstein-Barr-virus-infected BL2 cells.
    Doyle MG; Crawford DH
    Intervirology; 1994; 37(5):236-44. PubMed ID: 7698878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of human B-lymphocyte replication. II. Transforming Epstein-Barr virus exploits three distinct viral signals to undermine three separate control points in B-cell growth.
    Gordon J; Walker L; Guy G; Brown G; Rowe M; Rickinson A
    Immunology; 1986 Aug; 58(4):591-5. PubMed ID: 2426189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinoic acid and steroids inhibit Epstein-Barr virus-induced nuclear antigen, DNA synthesis and lymphocyte transformation.
    Sundar SK; Levine PH; Ablashi DV; Menezes J
    Anticancer Res; 1984; 4(6):415-8. PubMed ID: 6097161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus: exploiting the immune system.
    Thorley-Lawson DA
    Nat Rev Immunol; 2001 Oct; 1(1):75-82. PubMed ID: 11905817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infection of leukaemic B lymphocytes by Epstein Barr virus.
    Doyle MG; Catovsky D; Crawford DH
    Leukemia; 1993 Nov; 7(11):1858-64. PubMed ID: 8231253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus latent gene expression during the initiation of B cell immortalization.
    Allday MJ; Crawford DH; Griffin BE
    J Gen Virol; 1989 Jul; 70 ( Pt 7)():1755-64. PubMed ID: 2544663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic and biochemical evidence that EBNA 2 interaction with a 63-kDa cellular GTG-binding protein is essential for B lymphocyte growth transformation by EBV.
    Yalamanchili R; Tong X; Grossman S; Johannsen E; Mosialos G; Kieff E
    Virology; 1994 Nov; 204(2):634-41. PubMed ID: 7941331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the transformation of human lymphocytes by Epstein-Barr virus. II. Abortive response of leukemic cells to the transforming virus.
    Takada K; Yamamoto K; Osato T
    Intervirology; 1980; 13(4):223-31. PubMed ID: 6248483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous detection of the two main proliferation driving EBV encoded proteins, EBNA-2 and LMP-1 in single B cells.
    Rasul AE; Nagy N; Sohlberg E; Ádori M; Claesson HE; Klein G; Klein E
    J Immunol Methods; 2012 Nov; 385(1-2):60-70. PubMed ID: 22921685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient expression of the Epstein-Barr virus LMP1 gene in human primary B cells induces cellular activation and DNA synthesis.
    Peng M; Lundgren E
    Oncogene; 1992 Sep; 7(9):1775-82. PubMed ID: 1354347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Studies on transforming functions of Epstein-Barr virus-specific proteins].
    Kinoshita T
    Hokkaido Igaku Zasshi; 1990 Jul; 65(4):362-75. PubMed ID: 2172130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of Epstein-Barr virus transformation of human lymphocytes: susceptibility of B lymphocyte subpopulations and differentiation stage of the transformed cells].
    Koizumi S
    Hokkaido Igaku Zasshi; 1985 Sep; 60(5):724-34. PubMed ID: 3000906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.